Skip to content
PICO Portalanswers from OpenAlex

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer

PaperCitations, authors & open-access status

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer have?

PICO Portalcitation count

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer has 30 citations in the OpenAlex counts PICO Portal stores.

When was New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer published?

PICO Portalyear

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer has 2022 year in the PICO Portal index.

What is the open-access status of New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?

PICO Portaloa status

New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer has gold oa status in the PICO Portal index.

What is the DOI of New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?

PICO Portaldoi

The DOI for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is on the source record.

What is the PMID of New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?

PICO Portalpmid

The PMID for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is on the source record.

What is the OpenAlex record for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?

PICO Portalopenalex

The OpenAlex for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial